Back to results
US 2019/0194175 A1Published application
Salt forms of 4-cyano-n-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2h-pyran-4-yl)pyridin-3-yl)-1h-imidazole-2-carboxamide
AssigneeJanssen Pharmaceutica NV
InventorsNagy E. Fawzy, David Breslin
Life of this patent
Estimating the term…
Abstract
The present disclosure discusses salt forms of 4-cyano-N-[2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide.
Claims33
A pharmaceutically acceptable salt form of 4-cyano-N-[2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide (Compound A)
- wherein the pharmaceutically acceptable salt is selected from the group consisting of
- Compound A, sulfate salt;
- Compound A, phosphate salt;
- Compound A, mesylate salt;
- Compound A, tosylate salt;
- and
- Compound A, besylate salt.
4 more elements
Dependencies are inferred from the claim text.